Impact of hormone therapy on Medicare spending in the Women's Health Initiative randomized clinical trials

Menopausal hormone therapy increased spending for some diseases, but decreased spending for others. These offsetting effects led to modest (3%-4%), nonsignificant increases in overall spending among women aged 65 years and older.